Deliverable 3: Engaging Stakeholders





Table 1 Strategy Map

Stakeholder Specialists Patients Employees Dynamic Insurance Firm Colfax brand Community wellness
Representation Physicians Users Users Insurance companies Pharmaceutical


Roles/Responsibilities Provide users with quality care.

Assess quality during interactions.

Provide feedback on quality assurance.

Provide feedback on quality during care.

Articulate quality improvement required.

Ensure services are quality oriented.

Provide feedback on workplace quality.

Financing cover plans on timely basis.

Review quality with insurance plans.

Provide supplies on timely basis for quality.

Articulate quality through brand products.

Review quality measures.

Evaluate quality perspectives from community participants.

Stakeholder Power Legitimate Power Expert Power Expert Power Coercive Power Coercive Power Reward Power
Meeting times Weekly Daily Daily Monthly Monthly Weekly
Timeline Entire project time Entire project time Entire project time Six months Six months Entire project time


The project will consider the inclusion of cultural diversity among the key stakeholders. For instance, specialists and employees as per the organizational policy are recruited considering age, gender, ethnicity, and race (Johnson & Orr, 2020). This already shows the internal stakeholders reflect diversity. Social interactions between shareholders and interest groups provide dimensions in expectations and mobilizing interests to meet organizational needs (Johnson & Orr, 2020). Patients to be selected as participants in the project will also be considered under cultures and conditions (Neto & Borges, 2019). The pharmaceuticals and community wellness organizations will be required to provide the diversity and inclusivity policy to depict diversity considerations (Neto & Borges, 2019). Adaptive factors displayed by institutions in the macro context foster acceptance of current market dynamics (Neto & Borges, 2019). Thus, considering inclusivity policy would explore organizational adaptations of diversity (Neto & Borges, 2019).

Ensuring fairness and equity will entail the selection stakeholders through random sampling. This is after an evaluation of their reputation in the community (for the organizations). Final approval depends on adequacy of settlement in respect to participation, opportunities, and allocation schemes (McGovern & Rubenstein, 2020). Further, the process will entail fair background evaluations to avoid discriminatory instances. Alternatively, employees and specialists will be selected by their colleagues in different departments for representation. The selected individuals are required to build commitment and prioritize the mission. Internal stakeholders play an imperative role in influencing changes required in the strategy plan. Allowing the team mates to select their preferred candidates would effectively lead to fairness and equity (Jasti et al., 2019).


Stakeholder Survey

Key Questions

1. What do you think is critical in ensuring quality healthcare standards are met?

2. What are your organizational standards in meeting quality assurance?

3. What measurements could be deployed to measure, review, and evaluate? (Jasti et al., 2019).

4. Are KPI’s effective in measuring healthcare quality?

5. How will incorporating quality KPI’s in the organization impact operations, processes, and outcomes?

6. How do your internal stakeholders perceive of the current quality measures?

7. Will the workplace culture allow quality measure changes and how will they be integrated in a span of three months?

8. Do the current quality measures and quality integration levels up to the expected standard?

9. In your organization what necessitates quality assurance and how is it effectively embedded in your workplace policy? (McGovern & Rubenstein, 2020).

Effectiveness Questions

1. What are your thoughts on what should be included in our agenda for the next meeting?

2. How would you influence changes you feel are required to improve quality standards and measures?

3. What reviews would you provide in our current quality focus strategy?

4. Which measures would you incorporate in our organization to influence quality assurance?

5. What would you term as a satisfactory meeting regarding this project? (Neto & Borges, 2019).






















Jasti, B., Livesye, J., Oppenheimer, P., Boyce, E. & Long, T. (2019). Development, implementation, and assessment of a comprehensive strategy plan in a school pharmacy. American Journal of Pharmaceutical education, 83(6) 6899.

Johnson, S. & Orr, K. (2020). What is business school research for? Academic and stakeholder perspectives, politics, and relationability. Studies in higher education, 45(3) 557-578.

McGovern, F. & Rubenstein, W. (2020). The negotiation class: a cooperative approach to class actions involving large stakeholders. Texas law review, 99(73).

Neto, J. & Borges, J. (2019). Narratives of stakeholders under the perspective of the strategy as social practice. Revista de Administracao Mackenzie, 20(1).

Order your essay today and save 10% with the discount code ESSAYHELP